Latest Regulatory Milestones News

Aurum Resources has taken a major step forward at its Boundiali Gold Project in Côte d'Ivoire by lodging three mining licence applications covering over 570 square kilometres, setting the stage for a busy 2026 with extensive drilling and resource updates.

Viridis Mining and Minerals has secured a pivotal US$50 million Letter of Support from Export Finance Australia, finalising the export credit agency-led debt package for its Colossus Rare Earths Project. This milestone positions the project to advance towards full funding and a Final Investment Decision in the second half of 2026.

Memphasys Limited has extended the repayment terms of its convertible notes with major shareholder Peters Investments to mid-2026, reinforcing financial flexibility amid ongoing commercial progress.

Arovella Therapeutics has taken a significant step forward by submitting an IND application to the U.S. FDA for its lead CAR-iNKT cell therapy, ALA-101, targeting blood cancers. This milestone paves the way for a first-in-human Phase 1 trial in both Australia and the U.S.

Memphasys Limited has completed a $579K shortfall placement, boosting total funds raised to over $1.12 million to support the commercial rollout of its Felix™ System following recent regulatory approvals.

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.

Metallium Limited has initiated commissioning at its Texas Technology Campus following a successful first chlorine flash using its proprietary Flash Joule Heating technology, marking a significant step toward commercial operations.

DigiCo Infrastructure REIT has received key regulatory approval to expand its SYD1 data centre in Ultimo, NSW, enabling a significant capacity upgrade amid strong tenant demand.

High Peak Royalties finalises the sale of its geothermal subsidiary Torrens Energy to Northstar Energy, gaining significant equity and royalty interests while advancing South Australia's clean energy ambitions.

NEXTDC has received State Significant Development approval for its S4 Sydney Data Centre at Horsley Park, clearing a major regulatory hurdle for its expansion plans in New South Wales.

Caravel Minerals reports substantial progress on its Definitive Feasibility Study for the Caravel Copper Project, advancing engineering, environmental approvals, and strategic partnerships toward development.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.